Understanding a Gynecological Cancer Patient Experience​

A global pharmaceutical company wished to achieve a deep, empathetic understanding of the early and advanced stage patient experience for a gynecological cancer, including pain points and social determinants of health (SDoH) barriers.

Our client was seeking to identify areas of opportunity for a new indication of their oncology drug and to continue leading in the development of solutions for this lesser-known gynecological cancer patient community.​

Equipped with a detailed patient journey outlining the emotional experience, strategic opportunity spaces and a thorough list of drivers and barriers to diagnosis and treatment, the consumer and HCP marketing teams achieved a nuanced understanding of the patient and caregiver’s unmet needs, as well as the overall need of this specific cancer community to be seen. ​